Stay updated on Ganetespib Combo with Docetaxel in NSCLC Clinical Trial
Sign up to get notified when there's something new on the Ganetespib Combo with Docetaxel in NSCLC Clinical Trial page.

Latest updates to the Ganetespib Combo with Docetaxel in NSCLC Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedAdded a comprehensive Locations section listing study sites across numerous US states and international regions, including Arizona, California, Colorado, and many other locations worldwide.SummaryDifference3%

- Check20 days agoNo Change Detected
- Check27 days agoNo Change Detected
- Check34 days agoChange DetectedRevision label updated from v3.3.1 to v3.3.2. No substantive changes to study details, eligibility criteria, or results.SummaryDifference0.0%

- Check42 days agoChange DetectedRevision: v3.3.1 replaces v3.2.0 on the page; no study content or results were modified. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check49 days agoChange DetectedThe funding status notice about a lapse in government funding has been removed from the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check63 days agoChange DetectedNo significant changes detected between the two screenshots; core study details (title, NCT number, conditions, design, outcomes, and locations) remain the same, and only minor UI/formatting differences are observed, To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check92 days agoChange DetectedMajor update: page now includes a government funding status notice and indicates version 3.2.0, replacing the previous 3.1.0.SummaryDifference1%

Stay in the know with updates to Ganetespib Combo with Docetaxel in NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Ganetespib Combo with Docetaxel in NSCLC Clinical Trial page.